• 분석과학
• /
• 제15권5호
• /
• pp.410-416
• /
• 2002

본 연구에서는 LC - MS/MS를 이용해 혈장과 뇨중에서 반코마이신을 신속하게 정량분석하는 방법을 개발하였다. 크로마토그래피는 $C_{18}$ XTerra MS 컬럼 ($2.1{\times}30mm$, $3.5{\mu}m$)을 사용하여 분석하였다. 이동상으로는 0.25% 초산이 섞인 10% 아세토니트릴 용액을 사용하였으며, 유속은 $250{\mu}L/min$이다. 반코마이신과 카페인 (내부표준물질)은 multiple reaction monitoring (MRM) 방법을 사용하여 검출하였으며 반코마이신은 precursor ion m/z 725.0 ( $[M+2H]^{2+}$)와 product ion m/z 100.0을 사용하였다. 혈장에서 반코마이신의 검출한계는 1 nM이며 좋은 정확성과 정밀성을 보여주었다. 또한 혈장중에서 반코마이신의 정량범위는 $0.01{\mu}M$ - $100{\mu}M$이다. 혈장과 뇨중에서 반코마이신을 정량하는 이 분석방법은 약물동력학연구 및 관련연구에 성공적으로 적용되었다.

• 한국식품과학회지
• /
• 제38권2호
• /
• pp.313-316
• /
• 2006

장내 상주균이며 probiotics로 활용되고 있는 Bifidobacterium에 대한 항생제 내성분포를 분석하였다. 분석된 93개의 Bifidobacterium이 chlolurnphenicol, rifampicin, erythromycin에 대해서는 감수성을 갖고 있었고, aminoglycoside계 항생제, nalidixic acid와 vancomycin에 내성을 갖는 것으로 나타났다. 그리고 vancomycin의 MIC가 $100\;{\mu}g/mL$ 이상인 균이 전체 균주 중 34%를 차지했다. Tetracycline, erythromycin, penicillin에 대한 내성은 매우 다양하게 나타났다. ${\beta}-lactam$계 항생제인 penicillin G와 cephalothin은 10년보다 더 내성이 높아졌음을 알 수 있었고, ampicillin, amoxicillin, tetracycline은 항생제 농도가 점차 증가하고 있는 것으로 보인다. 인체유래 분리균과 유산균식품 분리균의 항생제 내성은 대부분 비슷한 특성을 보였으나 유산균식품 분리 균주중 vancomycin의 MIC가 $100\;{\mu}g/mL$ 이상인 균주가 약 20%가 되는 것으로 나타났다. 따라서 새로운 probiotics를 개발하기 위해서는 이러한 항생제 내성 특성을 분석하고 항생제 내성 위해성에 대한 검증이 필요한 것으로 보인다.

• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2005년도 International Meeting of the Microbiological Society of Korea
• /
• pp.143-147
• /
• 2005

The non-pathogenic, non-glycopeptide-producing actinomycete Streptomyces coelicolor carries a cluster of seven genes (vanSRJKHAX) that confers inducible, high-level resistance to vancomycin. The van genes are organised into four transcription units, vanRS, vanJ, vanK and vanHAX, and these transcripts are induced by vancomycin in a vanR-dependent manner. vanHAX are orthologuous to genes found in vancomycin resistant enterococci that encode enzymes predicted to reprogramme peptidoglycan biosynthesis such that cell wall precursors terminate in D-Ala-D-Lac, rather than D-Ala-D-Ala. vanR and vanS encode a two-component signal transduction system that mediates transcriptional induction of the seven van genes. vanJ and vanK are novel genes that have no counterpart in previously characterised vancomycin-resistance clusters from pathogens. VanK is essential for vancomycin resistance in S. coelicolor and it is required for adding Gly branch to stem peptides terminating D-Ala-D-Lac. Because VanK can recognise D-Lac-containing precursors but the constitutively expressed femX enzyme, encoded elsewhere on the chromosome, cannot recognize D-Lac-containing precursors as a substrate, vancomycin-induced expression of VanHAX in a vanK mutant is lethal. Further, femX null mutants are viable in the presence of glycopeptide antibiotics but die in their absence. Bioassay using vanJp-neo fusion reporter system also showed that all identified inducers for van genes expression were glycopeptide antibiotics, but teicoplanin, a membrane-anchored glycopeptide, failed to act as an inducer.

• 대한의생명과학회지
• /
• 제26권3호
• /
• pp.149-156
• /
• 2020

We developed a simple and rapid method for detecting vancomycin resistance genes, such as vanA and vanB, using loop-mediated isothermal amplification (LAMP). To identify not only vancomycin resistance genes, but also the genus Enterococcus, primers were designed for vanA, vanB, and 16S rRNA. Screening for vancomycin susceptibility in Enterococcus was performed using Etest (bioMérieux Inc). The results of the LAMP assay were compared to those of real-time RT-PCR. The optimal conditions for the LAMP assay were 65℃ for 60 min. The detection limits of the LAMP assay for vanA, and vanB were 2 × 10² copies/reaction. Compared to RT-PCR, the sensitivities and specificities of LAMP for 16S rRNA, vanA, and vanB were 100/100%, 100/100%, and 100/100%, respectively. The vanA genotype-vanB phenotype accounted for 57.5% (46/80) of the vancomycin-resistant Enterococci samples collected from 2016 to 2019. In conclusion, the LAMP assay developed in this study showed high sensitivity and specificity for vancomycin-resistant genes. Moreover, due to the simplicity and rapidity of the LAMP assay, its use can be very useful in clinical microbiology laboratories.

• 한국임상약학회지
• /
• 제6권2호
• /
• pp.1-6
• /
• 1996

Carcadian rhythm dependence of vancomycin pharmacokinetics was evaluated in 5 normal volunteers receiving a single intravenous 1.0 g dose of vancomycin at 8 o'clock in the morning and another occasion at 8 o'clock in the evening in a crossover manner. The serum data were subjected to simultaneous computer nonlinear least squares regression analysis using a two-compartment pbarmacokinetic model. The mean half-life of vancomycin was $4.78\pm0.81$ hr in the morning and $4.25\pm0.51$ hr in the evening. The mean total body clearance of vancomycin was $1.29\pm0.58$ hr in the morning and $5.58\pm0.48$ hr in the evening. No circadian rhythm was found to be apparent in normal volunteers. The mean in intrasubject difference in the half-life between 8 A.M. and 8 P.M. was $15.4\%$ with fluctuations ranging from $10.4\sim33.8\%$, It is reasonable to consider individual circadian rhythm for effective dosage regimen of vancomycin in clinical chronotherapeutics.

• Clinical and Experimental Pediatrics
• /
• 제51권11호
• /
• pp.1228-1231
• /
• 2008

반코마이신 투여 후에 발생하는 약물 과민성 증후군은 아주 드물게 보고되고 있다. 저자들은 11세 여자 환아에서 감염성 심내막염에 대한 치료로 반코마이신을 투여한 후 18일째부터 발열, 반구진성 발진이 관찰되어, 반코마이신 투여 중단 및 코르티코스테로이드를 투여한 지 24시간 이내에 임상 증상의 호전을 보인 약물 과민성 증후군 1예를 경험하였다. 본 증례의 환아에서는 발열, 반구진성 발진, 간염, 급성 신부전 등이 약물 과민성 증후군의 증상으로 관찰되었다.

• 한국미생물·생명공학회지
• /
• 제24권4호
• /
• pp.404-407
• /
• 1996

The effects of carbon sources on vancomycin production were investigated using Nocardia orientalis CSVC 3300. Among carbon sources tested, glucose, maltose and fructose were effective for the production of vancomycin. Glucose was favored for growth, but decrease the production of vancomycin at the concentration above 7.5%. In comparison, maltose did not decrease the production of vancomycin up to the concentration of 20%. When the mixture of glucose and maltose was used in the ratio 1:3 to 1:4, the highest production of vancomycin was achieved. When glucose concentration was set at 3.0%, catabolite repression could not be observed up to total sugar concentration of 16.0%. Fermentation was carried out using commercial hydrolyzed starch composed of glucose, maltose, maltotriose and maltotetraose, The initial glucose concentration was set at 3.0% and subsequent oligosaccharide consumption was monitored by checking their supernatant with HPLC. During initial cultivation for 38 hour, glucose was the sole carbon source leading to rapid growth. After cell growth stopped, the maltose and glucose concentrations increased due to degradation of maltotriose and maltotetraose, but glucose level was maintained at around 3.0%. After 70 hour fermentation, maltose slowly converted to glucose, and vancomycin production continued during the period.

• Journal of Korean Neurosurgical Society
• /
• 제66권5호
• /
• pp.536-542
• /
• 2023

Objective : Surgical site infection is the most detrimental complication following cranioplasty. In other surgical fields, intrawound vancomycin powder application has been introduced to prevent surgical site infection and is widely used based on results in multiple studies. This study evaluated the effect of intrawound vancomycin powder in cranioplasty compared with the conventional method without topical antibiotics. Methods : This retrospective study included 580 patients with skull defects who underwent cranioplasty between August 1, 1998 and December 31, 2021. The conventional method was used in 475 (81.9%; conventional group) and vancomycin powder (1 g) was applied on the dura mater and bone flap in 105 patients (18.1%; vancomycin powder group). Surgical site infection was defined as infection of the incision, organ, or space that occurred after cranioplasty. Surgical site infection within 1-year surveillance period was compared between the conventional and vancomycin powder groups with logistic regression analysis. Penalized likelihood estimation method was used in logistic regression to deal with zero events. All local and systemic adverse events associated with topical vancomycin application were also evaluated. Results : Surgical site infection occurred in 31 patients (5.3%) and all were observed in the conventional group. The median time between cranioplasty and detection of surgical site infection was 13 days (range, 4-333). Staphylococci were the most common organisms and identified in 25 (80.6%) of 31 cases with surgical site infections. The surgical site infection rate in the vancomycin powder group (0/105, 0.0%) was significantly lower than that in the conventional group (31/475, 6.5%; crude odds ratio [OR], 0.067; 95% confidence interval [CI], 0.006-0.762; adjusted OR, 0.068; 95% CI, 0.006-0.731; p=0.026). No adverse events associated with intrawound vancomycin powder were observed during the follow-up. Conclusion : Intrawound vancomycin powder effectively prevented surgical site infections following cranioplasty without local or systemic adverse events. Our results suggest that intrawound vancomycin powder is an effective and safe strategy for patients undergoing cranioplasty.

• 약학회지
• /
• 제45권5호
• /
• pp.491-493
• /
• 2001

Coagulase-negative Staphylococcus sp #39, isolated from raw-milk showed reduced susceptibility to vancomycin. The minimun inhibitory concentration for strain #39 was at 8$\mu\textrm{g}$ of vancomycin per ml. Transmitting electron microscopy displayed that this strain had a 2.5-3.5 times thicker cell wall than a vancomucin sensitive strain of Staphylococcus sp. The strain #39 also had an increased cell volume. These data indicate that the reduced susceptibility may be due to the thickness of the cell wall of the test strain.

• 대한의생명과학회지
• /
• 제5권1호
• /
• pp.95-100
• /
• 1999

일반적으로 임상검사실에서 vancomycin resistant enterococci (VRE)를 검출하는 일은 어렵고, 시간이 많이 들며, 검체처리 비용도 많이 든다. 따라서 본 실험은 임상검체에서 분리된 세균으로부터 VRE를 신속하게 확인하고, 진단하기 위한 방법으로서 다중 중합효소 연쇄반응을 확립하였다. 본 실험에 사용된 primer는 장구균에 특이 한 유전자인 vanA, vanB, vanC-1, vanC-2/3 각각의 염기서열을 기초로 primer를 제작하고, 다중 중합효소 연쇄 반응을 실시하여 임상검체로부터 분리된 VRE 유전자의 type및 분포율을 조사하고자 하였다. 국내에서 분리된 75주의 장구균을 대상으로 다중 중합효소 연쇄반응을 실시한 결과 36주의 분리균주에서 vancomycin에 대해 높은 저항성을 보이는 vanA 유전자를 가진 것으로 나타났다. 그리고 18주에서는 vancomycin에 낮은 저항성을 내성을 보이는 vanC-1 또는 vanC-2/3 유전자를 보유한 것으로 나타났다. 따라서 본 실험에서 확립한 다중 중합효소 연쇄 반응 기법은 신속한 VRE 진단 방법으로 이용할 수 있을 것이다.